# Pamish to supply nucleoside intermediates to Thermo Fisher Scientific

Pamish has signed a contract with Thermo Fisher Scientific to supply nucleoside pharmaceutical intermediates worth 1.347 billion KRW. The contract runs until August 14, 2020.

- Type: Contract
- Announced: 2020-03-06
- Value: $1.12M (1.35B KRW)
- Status: announced
- Products: nucleoside pharmaceutical intermediates
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Pamish](https://endata.com/companies/21624.md)
- [Thermo Fisher Scientific](https://endata.com/companies/7061.md) (customer)

## Sources

- [biz.heraldcorp.com](https://biz.heraldcorp.com/article/2248924), 2020-03-06: "파미셀은 미국 Thermo Fisher Scientific사와 의약중간체 뉴클레오시드(Nucleoside) 공급계약을 체결했다고 6일 공시했다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.